Shmuel Ben Zvi
Director/Miembro de la Junta en BANK LEUMI LE-ISRAEL B.M. .
Fortuna: - $ al 30/04/2024
Cargos activos de Shmuel Ben Zvi
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| BANK LEUMI LE-ISRAEL B.M. | Director/Miembro de la Junta | 29/07/2015 | - |
| Independent Dir/Board Member | 29/07/2015 | - | |
| PROTALIX BIOTHERAPEUTICS, INC. | Director/Miembro de la Junta | 30/06/2022 | - |
| Independent Dir/Board Member | 30/06/2022 | - | |
| Shmuel (Muli) Ben Zvi Ltd. | Corporate Officer/Principal | - | - |
Historial de carrera de Shmuel Ben Zvi
Antiguos cargos conocidos de Shmuel Ben Zvi.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| NOTABLE LABS, LTD. | Director/Miembro de la Junta | 01/09/2018 | 16/10/2023 |
| Independent Dir/Board Member | 01/09/2018 | 16/10/2023 | |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Officer/Principal | 01/01/2004 | 01/12/2014 |
| Israel Ministry of Defense | Corporate Officer/Principal | 01/01/2000 | 01/01/2004 |
| SOL-GEL TECHNOLOGIES LTD. | Director/Miembro de la Junta | 01/01/2018 | - |
| Independent Dir/Board Member | 01/01/2018 | - |
Formación de Shmuel Ben Zvi.
| Tel-Aviv University | Doctorate Degree |
Estadísticas
Internacional
| Israel | 8 |
| Estados Unidos | 2 |
Operativa
| Director/Board Member | 4 |
| Independent Dir/Board Member | 4 |
| Corporate Officer/Principal | 3 |
Sectorial
| Health Technology | 5 |
| Finance | 2 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 4 |
|---|---|
| BANK LEUMI LE-ISRAEL B.M. | Finance |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Health Technology |
| SOL-GEL TECHNOLOGIES LTD. | Health Technology |
| PROTALIX BIOTHERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 3 |
|---|---|
| Shmuel (Muli) Ben Zvi Ltd. | |
Vascular Biogenics Ltd.
 Vascular Biogenics Ltd. BiotechnologyHealth Technology Vascular Biogenics Ltd. is a clinical-stage biopharmaceutical company, which engages in the development of next-generation, targeted medicines for difficult-to-treat medical conditions. Its product candidates are built off of its platform technologies: Vascular Targeting System (VTS), a gene-based technology targeting newly formed blood vessels and Monocyte Targeting Technology (MTT), an antibody-based technology able to specifically inhibit monocyte migration for immune-inflammatory applications. The company was founded by Dror Harats and Jacob George on January 27, 2000 and is headquartered in Modi'in, Israel. | Health Technology |
| Israel Ministry of Defense | Government |
- Bolsa de valores
- Insiders
- Shmuel Ben Zvi
- Experiencia
